You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Episodic Migraine Headache

Showing 1 - 25 of 4,751
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

Recruiting
  • Migraine
  • +3 more
  • Click Digital Therapeutic
  • New York, New York
    Click Therapeutics
Aug 15, 2023

Migraine, Episodic Migraine, Headache Trial in New York (ReMMi-D Digital Therapeutic)

Recruiting
  • Migraine
  • +3 more
  • ReMMi-D Digital Therapeutic
  • New York, New York
    Click Therapeutics
May 10, 2023

miR-155 Expression in Episodic and Chronic Migraine

Recruiting
  • Migraine
  • +3 more
    • Pavia, Italy
      IRCCS Mondino Foundation
    Jun 7, 2023

    Migraine Headache, Arterial Stiffness, Vitamin K Deficiency Trial in Beirut (Vitamin K2 or menaquinone-7, Placebo)

    Not yet recruiting
    • Migraine Headache
    • +2 more
    • Vitamin K2 or menaquinone-7
    • Placebo
    • Beirut, Lebanon
      Lebanese American University Medical Center - Rizk Hospital
    Jul 5, 2023

    Migraine Headache Trial in Sherbrooke (Nutritional Ketogenic Supplement, Isocaloric supplement)

    Completed
    • Migraine Headache
    • Nutritional Ketogenic Supplement
    • Isocaloric placebo supplement
    • Sherbrooke, Quebec, Canada
      Diex Research Sherbrooke Inc.
    Dec 20, 2022

    Migraine Disorders, Chronic Migraine, Episodic Migraine Trial in Pavia (Monoclonal antibody targeting the CGRP pathway (ligand

    Recruiting
    • Migraine Disorders
    • +2 more
    • Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)
    • Pavia, Italy
      Headache Science & Neurorehabilitation Center
    Nov 23, 2023

    Migraine Headache Trial in San Luis Potosi (Valproate Sodium, Memantine)

    Completed
    • Migraine Headache
    • San Luis Potosi, Mexico
      Hospital Central Dr. Ignacio Morones Prieto
    May 16, 2022

    Daylight Saving Time Transitions on Sleep and Migraine

    Recruiting
    • Episodic Migraine
    • Daylight Savings time transitions
    • Peoria, Illinois
      OSF HealthCare Saint Francis Medical Center
    Feb 15, 2023

    Migraine Trial in Lørenskog, Trondheim (Cerebri biofeedback, Cerebri headache diary)

    Not yet recruiting
    • Migraine
    • Cerebri biofeedback
    • Cerebri headache diary
    • Lørenskog, Viken, Norway
    • +1 more
    Nov 7, 2022

    Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

    Recruiting
    • Migraine
    • +4 more
    • Innsbruck, Tirol, Austria
    • +2 more
    Oct 19, 2022

    Episodic Migraine Trial in Philadelphia (saline , Ibuprofen)

    Completed
    Has Results
    • Episodic Migraine
    • Philadelphia, Pennsylvania
      Jefferson Headache Center
    Aug 16, 2022

    Chronic Migraine, Headache, Episodic Migraine Trial in Philadelphia (Lidocaine 4% Topical Application Cream [LMX 4], Lidocaine

    Recruiting
    • Chronic Migraine, Headache
    • Episodic Migraine
    • Lidocaine 4% Topical Application Cream [LMX 4]
    • +2 more
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 15, 2022

    Migraine, Episodic Migraine, Phonophobia Trial in United States (Rimegepant)

    Recruiting
    • Migraine
    • +3 more
    • Phoenix, Arizona
    • +18 more
    Jun 3, 2022

    Migraine Trial in Japan (Atogepant, Placebo for Atogepant)

    Not yet recruiting
    • Migraine
    • Ichikawa-shi, Chiba, Japan
    • +49 more
    May 8, 2023

    Chronic Migraine, Episodic Migraine Trial in Japan (Atogepant 60 mg)

    Enrolling by invitation
    • Chronic Migraine
    • Episodic Migraine
    • Atogepant 60 mg
    • Matsuyama-shi, Ehime, Japan
    • +23 more
    Feb 7, 2022

    Migraine Disorders, Headache Disorders Trial in Hangzhou (Placebo, 90mg Idebenone, 270mg Idebenone)

    Recruiting
    • Migraine Disorders
    • Headache Disorders
    • Placebo
    • +2 more
    • Hangzhou, Zhejiang, China
      Kaiming Liu
    Jun 12, 2021

    Episodic Migraine Trial (Eptinezumab, Placebo)

    Not yet recruiting
    • Episodic Migraine
    • (no location specified)
    May 31, 2023

    Episodic Migraine Trial in Rochester (Bupivacaine HCl 0.5% Injectable Solution, Methylprednisolone 40 MG Injection)

    Not yet recruiting
    • Episodic Migraine
    • Bupivacaine HCl 0.5% Injectable Solution
    • Methylprednisolone 40 MG Injection
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Feb 22, 2023

    Episodic Migraine Trial (Dysport®, Placebo)

    Not yet recruiting
    • Episodic Migraine
    • Dysport®
    • Placebo
    • (no location specified)
    Sep 14, 2023

    Migraine, Episodic Migraine Trial in United States (Galcanezumab, Placebo, Rimegepant)

    Recruiting
    • Migraine
    • Episodic Migraine
    • Gilbert, Arizona
    • +75 more
    Jan 16, 2023

    Episodic Migraine, Migraine Disorders Trial in Matosinhos (Electronic Headache Diary, Paper Diary)

    Recruiting
    • Episodic Migraine
    • Migraine Disorders
    • Electronic Headache Diary
    • Paper Diary
    • Matosinhos, Porto, Portugal
      Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos
    Mar 30, 2021

    Episodic Migraine Trial in China, India, Russian Federation (Galcanezumab, Placebo)

    Completed
    Has Results
    • Episodic Migraine
    • Beijing, Beijing, China
    • +39 more
    Jul 27, 2022

    Migraine Headache Trial in United States (DFN-15 Active, DFN-15 Placebo)

    Completed
    Has Results
    • Migraine Headache
    • DFN-15 Active
    • DFN-15 Placebo
    • Birmingham, Alabama
    • +44 more
    Dec 15, 2022

    Migraine Headache Trial in United States (DFN-15 Active, DFN-15 Placebo)

    Completed
    Has Results
    • Migraine Headache
    • DFN-15 Active
    • DFN-15 Placebo
    • Birmingham, Alabama
    • +42 more
    Dec 15, 2022

    Chronic Migraine, Headache Trial in Alexandria (Lidocaine IV)

    Active, not recruiting
    • Chronic Migraine, Headache
    • Lidocaine IV
    • Alexandria, Egypt
      Alexandria University,Medical Research Institute
    Oct 25, 2023